Breast implants

The European Commission and its Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) has published two Scientific Advices related to breast implants and health. They are on 1) new scientific information on the safety of PIP breast implants and 2) the possible association between breast implants and anaplastic large cell lymphoma (ALCL).

The first piece of advice concerns whether there is sufficient new scientific information on the safety of PIP breast implants to warrant an update of the 2014 SCENIHR Opinion and based on the scientific information it has gathered and evaluated, the SCHEER concludes that this is not the case at present.

The second piece of advice is on the state of scientific knowledge on a possible association between breast implants and anaplastic large cell lymphoma (ALCL). The SCHEER concluded that, at present, there is insufficient scientific information available to establish a methodologically robust risk assessment on the potential association of breast implants with the development of ALCL.

To download the full advice on the safety of PIP breast implants from the ec.europa.eu website

To download the full advice on the association between breast implants and ALCL from the ec.europa.eu website